Evidence map›Paper›PMID 41230248›Full record

ArticleSchizophrenia bulletin open2025

Distress and Negative Subtypes of Schizophrenia: Identification, Characterization, and Neurostructural Profiles.

Brandee Feola, Anna S Huang, Jinyuan Liu, Victoria Fox, Kristan Armstrong, Baxter Rogers, Stephan Heckers, Jennifer Urbano Blackford, Neil D Woodward

Abstract read
In one paragraph

Article in Schizophrenia bulletin open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Brandee FeolaDepartment of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, TN 37212, United States.
Anna S HuangDepartment of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, TN 37212, United States.
Jinyuan LiuDepartment of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, TN 37212, United States.ORCID https://orcid.org/0000-0001-6689-8245
Victoria FoxDepartment of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, TN 37212, United States.
Kristan ArmstrongDepartment of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, TN 37212, United States.
Baxter RogersVanderbilt University Institute of Imaging Sciences, Vanderbilt University Medical Center, Nashville, TN 37212, United States.
Stephan HeckersDepartment of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, TN 37212, United States.ORCID https://orcid.org/0000-0003-3601-9910
Jennifer Urbano BlackfordDepartment of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, TN 37212, United States.ORCID https://orcid.org/0000-0002-0261-4845
Neil D WoodwardDepartment of Psychiatry and Behavioral Sciences, Vanderbilt University Medical Center, Nashville, TN 37212, United States.

Funding

Vanderbilt Institute for Clinical and Translational Research (VICTR) -Identifying correlates of functional immunity in SARS-CoV-2 convalescent plasmaUL1TR002243 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Paul A. Harris, Wesley H Self · 2017 to 2026
$130.7M
Imaging Hippocampal Function in PsychosisR01MH070560 · NIMH · VANDERBILT UNIVERSITY MEDICAL CENTER · PI HECKERS, STEPHAN · 2005 to 2025
$7.2M
Negative Valence Systems in SchizophreniaR01MH127018 · NIMH · VANDERBILT UNIVERSITY MEDICAL CENTER · PI FEOLA, BRANDEE, WOODWARD, NEIL D. · 2021 to 2025
$3.3M
NCATS NIH HHS UL1 TR002243NIMH NIH HHS R01 MH070560NIMH NIH HHS R01 MH127018
6 · The paper itself

Abstract

Background: Heterogeneity in schizophrenia spectrum disorders is a major challenge to implementing personalized medicine and uncovering etiological pathways. Recent work identified subtypes of schizophrenia that exhibit unique patterns of clinical symptoms and features using a common clinical scale. The current study sought to: (1) replicate prior identification of subtypes using the Positive and Negative Syndrome Scale (PANSS) in a new cohort of people with schizophrenia; (2) further characterize differences between subtypes in symptoms, affect, cognition, functioning, and personality; and (3) determine if brain structure abnormalities vary across subtypes. Study Design: Phenotypic data were obtained on 356 individuals with schizophrenia spectrum disorders. Structural brain magnetic resonance imaging data were acquired on a subset of 203 individuals with schizophrenia and 186 healthy people. A 2-step cluster analysis of PANSS data was used to identify subtypes of schizophrenia. Subtypes were compared on characteristics and brain volume. Study Results: Clustering revealed 3 clusters aligning with previous subtypes: distress, negative, and low symptom. The distress subtype demonstrated higher levels of negative emotions, neuroticism, and schizotypal personality traits. The negative subtype exhibited more severe cognitive impairment, higher levels of disorganized and anhedonia symptoms, and worse functioning. Abnormalities in cortical volumes followed a gradient, the negative subtype demonstrated the largest number of cortical regions with smaller volume relative to healthy people, followed by the distress subtype, then the low symptom subtype. In contrast, smaller subcortical volumes were consistent across subtypes. Conclusions: Our findings support the presence of subtypes of schizophrenia spectrum disorders that differ in affect, cognition, functioning, personality, and brain structure.

Indexed as

affectclusteringcognitionpsychosisstructural neuroimaging

Identifiers

PMID41230248
PMCPMC12603685

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.